Nanomedicine and Nanotechnology in Health Care

Biography

Dr. Alain L Fymat is a medical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (~ 350 publications including patents, books & monographs, book chapters, refereed articles) and has lectured extensively in the USA, Africa and Asia. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is Honorable Editor of the International Journal of Cancer Prevention and Current Research and the International Journal of Nanomedicine Research. He s also Editor of the Global Journal of Nanomedicine and the Journal of Nanobiotechnology. He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California).

Research Interest

Dr. Fymat’s current research interests lie at the interface between science and medicine, particularly molecular/personal/precision medicine, nanomedicine, human genetics/epigenetics/ecogenetics, and pharmacogenomics. His most recent publications deal with magnetic resonance Imaging with nanocontrasting materials, nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery including across the brain protective barriers, and drug manufacturing in Africa.